Clinical Trial Update: TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck [NA]

View source ↗

Summary

Update on Version 2.0 of a de-intensification protocol for transoral robotic surgery (TORS) in oropharyngeal cancer, detailing dose and neck-volume reductions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer
• Squamous Cell Carcinoma

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Oropharyngeal Cancer, Squamous Cell Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING